Company Analysis

Vyome Holdings, Inc. (HIND)

Nasdaq: HIND · Pharmaceutical Preparations · San Clemente, CA · filing with the SEC since 2008
Grade2.7
◀ Past 1.4● Present 1.8▶ Future 4.2
1 est.

The grade of Vyome Holdings, Inc.

Nine metrics read from its own filings, by tense
Headline grade
2.7/10
◀ Past1.425% of the headline
● Present1.835% of the headline
▶ Future4.240% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

1.4/1025% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed
0.4/10

Has it survived what it has been through?

21 warning events since 2017; the latest 2025-08-20.

weight 22% of this tense · 4th percentile among 497 sector filers · read for itself

From the record

Vyome Holdings, Inc.'s filings since 2017 show 21 warning events of 4 kinds: a notice about its exchange listing (8-K item 3.01, 9 times, the latest 2025-05-30); a warning not to rely on past financial statements (8-K item 4.02, the latest 2023-04-13); an auditor change (8-K item 4.01, 5 times, the latest 2025-08-20); a late-report notice (Form NT 10-K or NT 10-Q, 6 times, the latest 2025-05-15) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
2.6/10

What has it actually done, year after year?

-19.6% a year over 7 filed years; profitable in 0 of 10.

weight 45% of this tense · 26th percentile among 323 sector filers · read for its customers

From the record

Vyome Holdings, Inc.'s 7 filed years say what it did: revenue went from $4 million in fiscal 2014 to $320 thousand in fiscal 2025, down 19.6% a year; it rose in 3 of 6 years; the deepest fall was 97% from fiscal 2017 to fiscal 2024; net income was positive in 0 of 10 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span-19.6%bottom 15% of its family
  • the share of years revenue rosebottom 36% of its family
  • the share of filed years with a profitbottom 27% of its family
  • the deepest fall from a revenue peak97.4%bottom 26% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate
0.5/10

How has it treated the people who own it?

SI estimate 0.5/10, confidence 35 of 100 (one part).

weight 33% of this tense · 5th percentile among 464 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the share count over the years, which ranks in the bottom 5% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read
Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned
one part: the share count over the years, the one part on file, ranked among 464 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Vyome Holdings, Inc.'s shareholder treatment is put at 0.5 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 5% of 464 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

1.8/1035% of the headline grade · 3 of 3 filed

Financial health

as filed
1.8/10

Is it financially healthy right now?

ROE -273%: lost 273¢ per shareholder dollar. Leverage 42%: owes 42¢ per asset dollar.

weight 45% of this tense · 18th percentile among 473 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Vyome Holdings, Inc. lost about 273 cents for every dollar of shareholders' money, and gross profitability: its products earned about 3 cents per dollar of everything the company owns. Leverage: it owed about 42 cents per dollar of assets, and net share issuance: its share count grew 896722.4% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetsbottom 41% of its family
  • return on equitybottom 11% of its family
  • gross profit against assetsbottom 20% of its family
  • the share count against the year beforebottom 1% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
1.6/10

How strong is its position in its industry?

bottom 16% of 315 in its family; net margin -3209.7%.

weight 22% of this tense · 16th percentile among 315 sector filers · read for its customers

From the record

Vyome Holdings, Inc.'s standing among 315 graded names in its industry family: revenue of $320 thousand in fiscal 2025 ranks in the bottom 13% by size; a net margin of -3209.7% ranks in the bottom 19%; revenue growth of -34.9% a year over the last 3 filed years ranks in the bottom 15% (its annual reports).

What it rests on

  • revenue against the family$319,714bottom 13% of its family
  • net margin-3209.7%bottom 19% of its family
  • three-year revenue growth-34.9%bottom 15% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed
1.9/10

What are the people in charge doing?

bottom 19% of 315 in its family for leadership; chief executive since 2025.

weight 33% of this tense · 19th percentile among 315 sector filers · read for its shareholders

From the record

Vyome Holdings, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Nelabhotla, Venkateswarlu (President and CEO, as filed), filing under that title since 2025-09-11, 1.2 years (bottom 16% of its family); the 7 officers and directors filing in the last fifteen months have been on the record a median of 1.2 years (bottom 3%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 7 people in charge now (bottom 37%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

  • officer and director changes on Form 8-K, against the people in charge4 in three years among 7 peoplebottom 37% of its family
  • the median years the people in charge have filed1.2 yearsbottom 3% of its family
  • the chief executive's years on the record1.2 yearsbottom 16% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

4.2/1040% of the headline grade · 3 of 3 filed

Room to expand

as filed
5.2/10

How much room does it have to grow?

top 48% of 273 in its family for room to expand.

weight 33% of this tense · 52nd percentile among 273 sector filers · read for itself

From the record

Vyome Holdings, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $5 million against no long-term debt tagged leaves 76.7% of its assets as net cash, top 20% of its family; cash from operations less capital spending is -1172.6% of revenue (bottom 22%); a gross margin of 68.4% (bottom 48%); research spending of 184% of revenue (top 43%) (its annual report).

What it rests on

  • cash less debt against assets76.7%top 20% of its family
  • cash from operations less capital spending against revenue-1172.6%bottom 22% of its family
  • gross margin68.4%bottom 48% of its family
  • research spending against revenue184.0%top 43% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
2.8/10

What could actually drive growth from here?

bottom 28% of 306 in its family for growth drivers.

weight 45% of this tense · 28th percentile among 306 sector filers · read for its customers

From the record

Vyome Holdings, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew -34.9% a year over the last three filed years against -19.6% over all 7, slowing (bottom 28% of its family); the newest year grew 24.4% (top 34%); research spending grew -38.6% a year (bottom 9%); capital spending grew -65.1% a year (bottom 10%) (its annual reports). Vyome Holdings, Inc. reported 3 product lines in fiscal 2025: Product at $175 thousand (55%), License at $117 thousand (37%), Royalty at $28 thousand (9%); 1 of 2 grew against the year before (its annual report).

What it rests on

  • three-year growth against the whole span-15.3 points a yearbottom 28% of its family
  • the newest year's revenue growth24.4%top 34% of its family
  • three-year growth of research spending-38.6%bottom 9% of its family
  • three-year growth of capital spending-65.1%bottom 10% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
5.6/10

Did its newest year beat what its own record pointed to?

top 44% of 233 in its family for expectations against reality.

weight 22% of this tense · 56th percentile among 233 sector filers · read for its shareholders

From the record

Vyome Holdings, Inc.'s newest year against its own record: revenue of $320 thousand in fiscal 2025 came in 109.7% above the $152 thousand its prior three years' pace pointed to (top 13% of its family); net income of $10 million against a prior three-year average of $25 million (top 28%); a net margin of a loss larger than its revenue against losses larger than its revenue before (bottom 10%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace109.7%top 13% of its family
  • net income against the prior three years' average+58%top 28% of its family
  • net margin against its prior averagedown more than 100 pointsbottom 10% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton HIND · research, not advice